We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases 43 New Guidances on Product-Specific Bioequivalence
FDA Releases 43 New Guidances on Product-Specific Bioequivalence
The FDA published dozens of product-specific draft guidance documents offering recommendations on the design of bioequivalence studies to support ANDAs.